InnovAge (OTCMKTS:INNV) Stock Price Down 5.8% - Should You Sell?

Key Points

• InnovAge Holding Corp. (OTCMKTS:INNV) saw its stock price decrease by 5.8%, trading at $4.89 after previously closing at $5.19.
• The company’s trading volume was significantly lower, with approximately 8,818 shares changing hands, a drop of 81% from its average daily volume.
• InnovAge focuses on providing medical and ancillary services for seniors, operating through the Program of All-Inclusive Care for the Elderly (PACE) approach, offering a variety of in-home and in-center care services.

InnovAge Holding Corp. (OTCMKTS:INNV - )'s stock price was down 5.8% during mid-day trading on Thursday . The company traded as low as $4.89 and last traded at $4.89. Approximately 8,818 shares changed hands during trading, a decline of 81% from the average daily volume of 45,783 shares. The stock had previously closed at $5.19.

InnovAge Price Performance

The firm has a 50-day moving average of $4.02 and a 200 day moving average of $3.72. The company has a market capitalization of $668.70 million, a PE ratio of -15.90 and a beta of 0.52. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.57 and a quick ratio of 1.57.

InnovAge Company Profile

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.